TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas.
Saved in:
| Title: | TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas. |
|---|---|
| Authors: | Zhang Y; Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, United States., Barkdull S; Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, United States., Kontoyiannis PD; McGovern Medical School, University of Texas Health Science Center, Houston, TX, United States., Legarreta AF; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Ramalingam P; Department of Anatomical Pathology, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Aug 14; Vol. 15, pp. 1573801. Date of Electronic Publication: 2025 Aug 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1573801 |
